Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Journal of Antibiotics|July 13, 2006
Antitumor effect of kigamicin D on mouse tumor modelsToru Masuda, Shunichi Ohba, Manabu Kawada, et al.
The International Journal of Biochemistry & Cell Biology|March 22, 2002
Evidence for a dimeric structure of rat liver serine dehydrataseHirofumi Ogawa, Tomoharu Gomi, Fusao Takusagawa, et al.
International Journal of Hematology|November 27, 2022
Endothelial function testing before conditioning therapy is useful for predicting transplant-related complications after allogeneic hematopoietic cell transplantationShojiro Haji, Motoaki Shiratsuchi, Akiko Takamatsu, et al.
European Journal of Haematology|April 23, 2022
Circulating endothelial cells and endothelial progenitor cells as potential predictors of acute GVHD after allogeneic hematopoietic stem cell transplantationAkiko Takamatsu, Yasuhiro Nakashima, Shojiro Haji, et al.
The Journal of Antibiotics|July 13, 2006
Augmentation of cellular immunity by kigamicin DToru Masuda, Shunichi Ohba, Manabu Kawada, et al.
International Journal of Hematology|May 20, 2019
Transformation of follicular lymphoma to double-hit lymphoma during adjuvant chemotherapy for concurrent ovarian carcinomaTaisuke Narazaki, Yasuhiro Nakashima, Yasuhiro Tsukamoto, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 2, 2019
Schizophyllum commune sinusitis after allogeneic bone marrow transplantation for myelodysplastic syndrome: A case report and literature reviewTaisuke Narazaki, Yasuhiro Nakashima, Yasuhiro Tsukamoto, et al.
Iscience|August 22, 2022
Identification of a drug-response gene in multiple myeloma through longitudinal single-cell transcriptome sequencingToru Masuda, Shojiro Haji, Yasuhiro Nakashima, et al.
Acta Haematologica|July 11, 2019
Intestinal Behçet's Disease with Primary Myelofibrosis Involving Trisomy 8Taisuke Narazaki, Motoaki Shiratsuchi, Mariko Tsuda, et al.
International Journal of Hematology|August 6, 2022
Rapid decrease in eGFR with concomitant use of tyrosine kinase inhibitors and renin-aldosterone-angiotensin system inhibitors in patients with chronic myelogenous leukemiaMariko Tsuda, Akie Hirata, Shoji Tokunaga, et al.
Pageof 2